AARDEX Group

Daily Archives: April 21, 2022

FDA Diversity Guidance

FDA Issues Draft Diversity Guidance to Improve Enrollment of Participants from Underrepresented Patient Populations

Diversity in clinical research is a growing concern for sponsors as many factors can influence how an individual may react to certain drugs: age, biological sex, disabilities, chronic comorbidities, geographical location, gender identity, race, and ethnic background.  Thus, if the … Read More